Center Laboratories, Inc. (TPEX: 4123)
Health Care · Pharmaceuticals · TW
NT$31.35
+0.48% today · -3.6% 1Y
Center Laboratories, Inc. (TPEX: 4123) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $775.56M and employs 182 people.
Over the last twelve months the share price has lost 3.6%, trading between 29.35 and 48.96.
Tweenvest scores Center Laboratories, Inc. across four factors: quality 46/100, value 46/100, growth 69/100, dividend 75/100. Its strongest factor is dividend.
4123 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $775.56M
- Revenue (TTM)
- $52.07M
- P/E
- 24.66
- EPS
- 1.27
- Dividend yield
- 5.31%
- Beta (5Y)
- 0.25
- 52-week high
- NT$48.96
- 52-week low
- NT$29.35
- Avg volume (3M)
- —
- Shares outstanding
- 791.02M
- Employees
- 182
- Next earnings
- —
About Center Laboratories, Inc.
Center Laboratories, Inc. operates as a Taiwanese pharmaceutical enterprise, with its primary focus lying in the manufacturing and distribution of various medical products across Taiwan. Beyond its core drug operations, the firm is heavily invested in the research and development of both small molecule therapeutics and biologics, including proteins and antibodies. Additionally, its extensive portfolio encompasses pharmaceutical CDMO services, medical devices, nutritional health products, agribiotechnology initiatives, advanced stem cell and immune cell therapies, and even strategic ventures in industry investment funds and venture capital. Founded in 1959, Center Laboratories maintains its headquarters in Taipei, Taiwan.
- ISIN
- TW0004123005
- Founded
- 1959
- Listed since
- Dec 31, 2007
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shouyao Holdings (Beijing) Co., LTD.SHSE: 688197 | $788.44M | CN¥35.51 | -5.81% |
| Shanxi Zhendong Pharmaceutical Co.,LtdSZSE: 300158 | $786.66M | CN¥5.31 | +1.92% |
| Teyi Pharmaceutical Group Co.,LtdSZSE: 002728 | $780.82M | CN¥10.24 | +3.33% |
| Shandong Jincheng Pharmaceutical Group Co., LtdSZSE: 300233 | $780.40M | CN¥13.78 | +1.32% |
| CHO Pharma, Inc.TPEX: 6586 | $773.05M | NT$115.50 | -0.86% |
| Guizhou Sanli Pharmaceutical Co.,LtdSHSE: 603439 | $758.35M | CN¥12.55 | -4.78% |
| Heilongjiang ZBD Pharmaceutical Co., Ltd.SHSE: 603567 | $756.62M | CN¥5.40 | +2.66% |
| DongKook Pharmaceutical Co., Ltd.KOSDAQ: A086450 | $751.63M | ₩22,400.00 | -1.54% |
Figures last refreshed Oct 11, 2026.